Annual Biological Production Forum 2012 in Dusseldorf

Aug. 6, 2012 - PRLog -- The global biological production industry is under pressure amidst challenging price restrictions, US health care reforms and reduced revenues. The agenda features a pharma QBD case study stream as well as keynote sessions, interactive workshops and networking activities.

Some of the key topics to be discussed are:

• Minimising Human Error To Optimise Manufacturing
• Successfully Meeting Virus Safety Requirements
• Designing A New Product Facility
• Successfully Designing A Single Use Facility
• Successfully Meeting Supply And Demand For Vaccine Production

Attendees will gain knowledge and expertise on the latest upstream and downstream strategies and single use technologies and disposables available to improve their organisational performance.

Enjoy case studies from leading biopharmacuetical organisations including Bayer, GSK, Roche, Novartis, Pfizer, UCB, Sanofi Pasteur and discuss critical biomanufacturing issues such as QBD, cost reduction and improving upstream and downstream processes.

For more information please visit www.biologicalproduction.com?mc=LBG26, call +44 (0)207 202 7690 or email enquire@wtgevents.com."

Attendance cost: £1995

Event organizer: World Trade Group


Get more information and register for the 11th Annual Biological Production Forum 2012 at http://itevent.net/11th-annual-biological-production-foru...

---

ITEVENT.NET is the largest listing of IT training courses and conferences provided by global corporations (such as Microsoft, IBM and Oracle) and independent consultants from IT, telecom, web and other technology and computer related industries. More IT events can be found on http://itevent.net